🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival: “For every 16 people, exercise prevents 1 person from recurrent/new cancer” “For every 14 people, exercise prevents 1 person from dying”

🫁 Breakthroughs mean nothing if patients can’t reach them. IMDELLTRA (tarlatamab) just cut the risk of death by 40% in small cell lung cancer - adding 5+ months of life. But across Europe, access is unequal. People are waiting & time is the one thing they don’t have. #SCLC

Brand new #GPsTalkCancer episode out now! ✨ Matthew Evison, Consultant Chest Physician, joins Sarah and Rebecca to provide his insights on lung cancer risk, exploring family history, never-smokers and the impact of environmental and occupational exposures, such as asbestos.

This episode also offers practical advice on how GPs can support early lung cancer diagnosis, such as how to use a chest X-ray, screening updates and the latest tools in smoking cessation. Listen now wherever you get your podcasts 🎧 link.gatewayc.org.uk/june25lungupda… #lungcancer

🗣️ “It’s unique in that level of harm...” Smoking has killed 8 million people in the UK in the last 50 years. In the latest #GPsTalkCancer episode, Consultant Chest Physician Matthew Evison discusses the level of harm caused by tobacco use and addiction on population health.

Matt discusses the importance of proactive smoking support in primary care, sharing his insights on vaping and shisha use, as well as how GPs can utilise the latest tools in smoking cessation. Out now wherever you get podcasts 🎙️ link.gatewayc.org.uk/june25lungupda… #lungcancer

A turning point in cancer care. The CHALLENGE trial shows exercise after cancer treatment reduces recurrence by 28% and mortality by 37%. If this were a drug, we’d prescribe it tomorrow. It’s time we prescribe movement. 📝 Read my latest blog: lucygossage.com/exercise-is-me…

Greater Manchester has achieved the national target for smoking in pregnancy rates, with numbers at an all time low. We spoke to Treating Tobacco Dependency Lead for NHS GM, Jane Coyne, to get her thoughts on this significant achievement. #SmokeFreePregnancy #MakeSmokingHistory

Why are so many young women getting #lungcancer? Our co-founder Janclark’ daughter Amy was just 20. Jules was 37 and Mel just 52. Worth reading Meike Leonard’s article featuring Matthew Evison & Will Hill The Francis Crick Institute on this trend 👇 dailymail.co.uk/health/article…

ESMO updated guidelines now include osimertinib + chemo as 1st-line for EGFR+ #lungcancer. Amivantamab combinations also added post-progression. Time for UK access to catch up‼️ #LCSM annalsofoncology.org/article/S0923-… ESMO - Eur. Oncology

This is huge - significant PFS benefit from adjuvant chemotherapy in patients with high risk stage 1A-IIA non-squamous NSCLC #lungcancer - practice changing! BTOG Greater Manchester Cancer Alliance MFT NHS British Thoracic Society (BTS) @iaslc

London bound for an important discussion on lung cancer screening with Roy Castle Lung Cancer Foundation & colleagues

What an incredible impact Roy Castle Lung Cancer Foundation have had over 35 years on improving outcomes for people diagnosed with lung cancer. An honour to celebrate with friends at Downing Street & also discuss the rapid and comprehensive implementation of #lungcancer screening

Experts like these are the driving force of the NHS, UK research and a lifeline for patients. With the strength of Roy Castle Lung Cancer Foundation behind it, we keep moving forward—bringing hope, care, and change #LCSM #35AnniversaryRCLF Sanjay Popat LungSpecialist Tom Newsom-Davis BTOG

🆕 Nature study on #lungcancer in never-smokers challenges long-held assumptions. ✅ Air pollution linked to key mutations ✅ EGFR most common in East Asia ❌ Secondhand smoke not a major factor - minimal genomic impact 68% of our EGFR+ UK members (2024 data) are never-smokers